Atlas Trials

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

Clinical trial NCT07294677 · RECRUITING

Trial details

NCT number
NCT07294677
Sponsor
University of Chicago
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphoma
Start date
2026-03-17
Primary completion
2032-03-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.